Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$276M |
| 2 |
IBM
IBM
|
+$272M |
| 3 |
Procter & Gamble
PG
|
+$161M |
| 4 |
Colgate-Palmolive
CL
|
+$151M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$405M |
| 2 |
CELG
Celgene Corp
CELG
|
+$207M |
| 3 |
Booking.com
BKNG
|
+$123M |
| 4 |
Eli Lilly
LLY
|
+$114M |
| 5 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.92% |
| 2 | Healthcare | 13.46% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Industrials | 10.52% |
| 5 | Consumer Staples | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CCMP
751
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $11.8M | 0.03% |
264,700
+12,200
| +5% | +$528K |
|
752
Crane NXT
CXT
$2.96B
| $11.8M | 0.03% |
457,473
-207,838
| -31% | -$5.25M |
|
753
Sibanye-Stillwater
SBSW
$7.42B
| $11.8M | 0.03% |
1,133,503
+755,858
| +200% | +$7.25M |
|
|
NP
754
DELISTED
Neenah, Inc. Common Stock
NP
| $11.8M | 0.03% |
221,700
+88,600
| +67% | +$4.5M |
|
|
ARG
755
DELISTED
Airgas Inc
ARG
| $11.8M | 0.03% |
+107,900
| New | +$11.5M |
|
756
Dentsply Sirona
XRAY
$2.31B
| $11.7M | 0.03% |
247,658
-481,600
| -66% | -$22.4M |
|
757
Chesapeake Utilities
CPK
$3.26B
| $11.7M | 0.03% |
246,300
+16,500
| +7% | +$716K |
|
758
Newell Brands
NWL
$2.63B
| $11.7M | 0.03% |
377,600
-191,521
| -34% | -$5.73M |
|
|
TRW
759
DELISTED
TRW AUTOMOTIVE HOLDINGS CORP
TRW
| $11.7M | 0.03% |
130,700
-224,964
| -63% | -$18.8M |
|
|
GNC
760
DELISTED
GNC Holdings, Inc.
GNC
| $11.7M | 0.03% |
343,000
+244,300
| +248% | +$9.73M |
|
|
AMRI
761
DELISTED
Albany Molecular Research Inc
AMRI
| $11.7M | 0.03% |
579,842
-116,848
| -17% | -$1.98M |
|
|
ARO
762
DELISTED
Aeropostale Inc
ARO
| $11.6M | 0.03% |
3,315,212
+3,004,260
| +966% | +$12.8M |
|
|
CEO
763
DELISTED
CNOOC Limited
CEO
| $11.5M | 0.03% |
64,100
-54,200
| -46% | -$9.17M |
|
|
EXAM
764
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
| $11.5M | 0.03% |
361,600
+20,308
| +6% | +$666K |
|
|
ACH
765
Accendra Health
ACH
$84.6M
| $11.5M | 0.03% |
337,150
-150,573
| -31% | -$5.16M |
|
|
PGH
766
DELISTED
Pengrowth Energy Corporation
PGH
| $11.4M | 0.03% |
1,590,436
+1,057,333
| +198% | +$6.9M |
|
767
Whirlpool
WHR
$2.79B
| $11.4M | 0.03% |
+81,957
| New | +$12M |
|
768
GE Aerospace
GE
$374B
| $11.4M | 0.03% |
90,547
-121,602
| -57% | -$15.5M |
|
769
Lear
LEA
$8.16B
| $11.4M | 0.03% |
127,600
-43,734
| -26% | -$3.76M |
|
770
Mercantile Bank Corp
MBWM
$1.06B
| $11.4M | 0.03% |
497,415
+63,603
| +15% | +$1.32M |
|
|
CPWR
771
DELISTED
COMPUWARE CORP
CPWR
| $11.4M | 0.03% |
1,184,380
+558,413
| +89% | +$5.45M |
|
772
Suburban Propane Partners
SPH
$1.17B
| $11.3M | 0.03% |
246,167
+154,029
| +167% | +$6.92M |
|
|
CZZ
773
DELISTED
Cosan Limited
CZZ
| $11.3M | 0.03% |
834,800
-322,692
| -28% | -$4.11M |
|
774
NETSCOUT
NTCT
$2.89B
| $11.3M | 0.03% |
+254,500
| New | +$9.88M |
|
|
CTCT
775
DELISTED
CONSTANT CONTACT, INC COM
CTCT
| $11.3M | 0.03% |
351,413
+11,100
| +3% | +$309K |
|
Similar funds
Jim Simons's Q2 2014 Portfolio in Review
As of Q2 2014, Jim Simons held 3,246 positions worth $42.9B, up 2.9% from $41.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons's Q2 2014 filing shows 450 new, 1,273 increased, 1,008 reduced and 492 closed positions. Its largest new stake was Procter & Gamble: 2,001,729 shares worth $157M. The largest sale was Verizon, an estimated $405M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2014 buy was Procter & Gamble: 2,001,729 shares worth $157M.
- Jim Simons added most to Pfizer in Q2 2014, an estimated $276M increase.
- Jim Simons's biggest Q2 2014 reduction was Verizon, cutting an estimated $405M.
- Jim Simons fully exited Booking.com in Q2 2014, selling an estimated $123M.
- Jim Simons's ten largest holdings make up 14% of its $42.9B portfolio in Q2 2014.
- Jim Simons opened 450 new positions and closed 492 in Q2 2014.
- Jim Simons's portfolio value rose 2.9% quarter-over-quarter to $42.9B.
Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.